Figure 8.
![Figure 8. Minimal residual disease (MRD) kinetics after autologous stem cell transplantation (SCT) and non-myeloablative allogeneic SCT.40. / MRD levels (number of CLL specific DNA copies per total DNA copies in the sample compared to the reference [pre-therapeutic] sample) of patients after myeloablative conditioning and auto-SCT and after non myeloablative allogeneic SCT. Black-filled symbols (circles and triangles) denote MRD-positive samples whereas blank symbols denote the sensitivity of PCR-negative samples (calculated minimum MRD level, which would have been detected in this particular sample).](https://ash.silverchair-cdn.com/ash/content_public/journal/hematology/2004/1/10.1182_asheducation-2004.1.163/4/byrd_fig8.jpeg?Expires=1724147208&Signature=Rn2J8nLdYpyY6Y3LewCLmOMRST3b67RJzmOgmsAc2cHJejglI6e2pEgm606msIbZYntsGNZLnau1-Pmv0by~YHFPXDix2rdjmIWA6gzrDwElUZbctY~Mcql1Mu586nka1fas1JrTcl0HafjNs4HvieANPTqsTLDQj6yw22Qh2sSvwh-xDiIyslRADMx5u4cUL4UbuBRNGNSriUuEav7oCwx5t7eUu-KJ0Of2zyraKG-2bO6xfX~gihI7e4psqs0PtI8uk2joDUxy9P9Pzf~kWtYShWMxTZM8mcL~keyaf2TnXUZdeuw3ebcIwrltSsgeMqJNFrZiRM3dOyNl1fMfqw__&Key-Pair-Id=APKAIE5G5CRDK6RD3PGA)
Minimal residual disease (MRD) kinetics after autologous stem cell transplantation (SCT) and non-myeloablative allogeneic SCT.40
MRD levels (number of CLL specific DNA copies per total DNA copies in the sample compared to the reference [pre-therapeutic] sample) of patients after myeloablative conditioning and auto-SCT and after non myeloablative allogeneic SCT. Black-filled symbols (circles and triangles) denote MRD-positive samples whereas blank symbols denote the sensitivity of PCR-negative samples (calculated minimum MRD level, which would have been detected in this particular sample).
